-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
January 01, 2009 - Medicare Parts A, B, and D Beneficiaries With Hypertension, With Use of One or More Antihypertensive Drugs … , With
Hypertension and Use of One or More Antihypertensive Drugs, and Average Number of Antihypertensive … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use
of One or More Antihypretensive Drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
October 01, 2017 - These reviews focus on a variety of issues, including assessing and comparing clinical
drugs, treatments … I feel like the thing that I'm most struggling with from an evidence-based standpoint, is
limiting pharmaceuticals … o What are the opportunities to substitute less costly, but equally effective,
pharmaceuticals for specific … These reviews
focus on a variety of issues, including comparing clinical drugs or treatments, and interventions … o Prevention strategies
o Diagnostic strategies
o Treatment strategies
Drugs, devices, non-pharmaceuticals
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-refinement_methods.pdf
January 01, 2013 - Disease-Modifying Antirheumatic Drugs
(DMARDs) in Children With Juvenile
Idiopathic Arthritis (JIA) … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … Disease-Modifying Antirheumatic Drugs
(DMARDs) in Children With Juvenile
Idiopathic Arthritis (JIA) … PICO
(Intervention):
Corticosteroids;
Synthetic disease-
modifying anti-
rheumatic drugs
(DMARDs)
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
May 01, 2019 - use
of ovulation-induction agents including oral
(clomiphene citrate or letrozole) and injected
drugs … Use of
fertility drugs and risk of ovarian cancer: results from
a U.S.-based case-control study. … Risk of ovarian
cancer in women treated with ovarian stimulating
drugs for infertility. … Effects
of fertility drugs on cancers other than breast and
gynecologic malignancies. … Long-term
relationship of ovulation-stimulating drugs to breast
cancer risk.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
January 01, 2014 - Should drugs be
administered right before PCI, 6 hours prior, 12 hours prior if
possible? … I found the descriptions of the
classes of drugs very helpful. … This is already a very
large report, and delving further into the background
for these drugs is out … UFH
given the small number of studies with a head-to-
head comparison of those drugs. … However, in KQ 1, all three drugs
were compared.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
January 01, 2007 - conduct and support research on the comparative
outcomes, clinical effectiveness, and appropriateness of pharmaceuticals … currently used interventions, including angioplasty
with stent placement and/or those antihypertensive drugs … explicitly evaluated aggressive medical treatment with ACE
inhibitors, statins, and anti-platelet drugs … after
revascularization do occur in a small percentage of patients, and each of the
antihypertensive drugs … eligibility criteria reported analyses of whether
periprocedural interventions, such as different drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_disposition-comments.pdf
August 23, 2013 - Initially, these
interventions were grouped together and labeled
‘medical’ because drugs and surgeries … I cannot see any
advantage to lumping these drugs together but if you do want to
group them, the only … We refer to gabapentin, baclofen,
alprazolam, and acamprosate as
neurotransmitter drugs and specify … Two of these feature experimental drugs that are not currently
commercially available and this may be … Similarly, the grouping of
antidepressants were in fact 4 different drugs
with differing doses.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
August 01, 2013 - , Bleeding history or predisposition,
Labile international normalized ratio, Elderly [>65
years], Drugs … Despite all the potential advantages of the new drugs
demonstrated in the clinical trials when compared … with
warfarin, the new drugs still do not have a well-validated
and -studied immediate antidote. … The shorter
half-life of the novel drugs may help in the management
of bleeding episodes in patients … receiving these drugs and
should provide comfort that bleeding can be controlled
without an antidote
-
effectivehealthcare.ahrq.gov/sites/default/files/fecal-incontinence_disposition-comments.pdf
March 21, 2016 - For
example, the easiest treatments to study (drugs)
are not necessarily those that are used most … With diet drugs being
'symptom' and replacing sphincter being 'cure' - the issue
would be what does … Stool modifying drugs are listed as BOTH
pharmacological treatments and standard care treatments. … We assume that the Reviewer is referring to
diet, over the counter drugs, PFMT, education,
toileting … offers any advantage over standard care (such
as dietary fiber supplementation, stool-
modifying drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
September 01, 2011 - support research with a focus on
outcomes, comparative clinical effectiveness, and appropriateness of pharmaceuticals … “Treating Type 2
Diabetes, The Oral Diabetes Drugs,
comparing Effectiveness, Safety, and Price.” … Consumer Reports Best Buy Drugs.
Yonkers, NY: Consumers Union; 2006.
8.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - These new data may
clarify any effect on mortality and gauge the comparative
effectiveness of these drugs … Additionally, combination drug therapy (using multiple
drugs with different mechanisms of action) is … In order to
5
optimize PAH care, newer information regarding the latest
drugs and combination therapies … compared a single drug (monotherapy)
with placebo or standard therapy and included the
following drugs … Drugs did not significantly differ in
their odds of causing dizziness or diarrhea.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atrial-fibrillation_research-protocol.pdf
May 22, 2012 - Radiofrequency ablation vs antiarrhythmic
drugs as first-line treatment of symptomatic atrial fibrillation … Catheter ablation versus antiarrhythmic drugs for
atrial fibrillation: the A4 study. … nebivolol, timolol)
• Calcium channel blockers
(verapamil, diltiazem)
Clarification that these drugs … nebivolol, timolol)
• Calcium channel blockers
(verapamil, diltiazem)
Clarification that these listed
drugs … cardioversion and patient-
enabled cardioversion using
an ICD
• Studies investigating use of
antiarrhythmic drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - bleeding;; In vitro
fertilization;; Precocious puberty;; Prostate cancer
AstraZeneca
Pharmaceuticals … indications:
Endometrial hyperplasia;; Endometriosis;;
Menopausal symptom
Bayer Healthcare
Pharmaceuticals
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
November 01, 2012 - injection
drug users.16-22 About 60 percent of new infections occur
in individuals who report injecting drugs … partners, unprotected sex, and/or sex with a person
infected with HCV infection or using injection drugs … Recommendations for
Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women
for Maternal Health
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … It
differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
March 01, 2017 - If inflammation is part
of the disease process, anti-inflammatory drugs may be
effective. … Nonsteroidal
Anti-
Inflammatory
Drugs (NSAIDs)
• No evidence was available for the effect of low-dose … Antidementia
Treatments
• Low-strength evidence shows AChEI antidementia drugs did not reduce the incidence … instrumental activities of daily living;
MCI=mild cognitive impairment; NSAIDs=nonsteroidal anti-inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
March 01, 2017 - If inflammation is part
of the disease process, anti-inflammatory drugs may be
effective. … Nonsteroidal
Anti-
Inflammatory
Drugs (NSAIDs)
• No evidence was available for the effect of low-dose … Antidementia
Treatments
• Low-strength evidence shows AChEI antidementia drugs did not reduce the incidence … instrumental activities of daily living;
MCI=mild cognitive impairment; NSAIDs=nonsteroidal anti-inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-200-comments-post-acs.pdf
November 14, 2017 - It is important that this list
should not be interpreted as an endorsement of any of
these drugs so … this point should be made the first time
these drugs are mentioned. … The
authors make it clear later in this report that the safety of
the majority of these drugs has not … In both
COPES and CODIACS, the study psychiatrist prescribed
the drugs if the patient preferred an
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
April 11, 2018 - considerations for AECOPD include short-
acting/long-acting inhaled bronchodilators, anti-inflammatory drugs … in patients with advanced
COPD suffering from an episode of AECOPD is unclear, especially as these drugs … mechanical ventilations
• Complementary and
alternative medicine
interventions
• Investigational drugs … and
drugs that are only available
outside of the U.S
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
September 01, 2011 - $3,355
per employee during a 3-year observation
period—approximately 65 percent related
to prescription drugs … .1 At the same time, it
is well recognized that some drugs used to
treat GERD (such as proton pump
inhibitors … Among them are the publication
of approximately 3,000 new studies; the introduction of
novel drugs; the … The large disease burden,
economic impact, and market potential for new drugs
and devices explain the